02:38:37 EDT Sun 12 Jul 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:IMLFF from 2019-07-11 to 2020-07-10 - 77 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2020-07-07 07:30U:IMLFFNews ReleaseInMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755
2020-07-07 07:30U:IMLFFNews ReleaseInMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755
2020-06-30 18:18U:IMLFFNews ReleaseInMed Announces Completion of Share Consolidation
2020-06-30 18:18U:IMLFFNews ReleaseInMed Announces Completion of Share Consolidation
2020-06-24 07:30U:IMLFFNews ReleaseInMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System
2020-06-24 07:30U:IMLFFNews ReleaseInMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System
2020-06-19 18:20U:IMLFFNews ReleaseInMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation
2020-06-19 18:20U:IMLFFNews ReleaseInMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation
2020-05-27 07:30U:IMLFFNews ReleaseInMed Releases CBN Preclinical Results in Glaucoma
2020-05-27 07:30U:IMLFFNews ReleaseInMed Releases CBN Preclinical Results in Glaucoma
2020-05-19 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
2020-05-19 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
2020-05-14 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2020-05-14 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2020-05-12 07:30U:IMLFFNews ReleaseInMed Files PCT Patent Application for Neuroprotection in Glaucoma
2020-05-12 07:30U:IMLFFNews ReleaseInMed Files PCT Patent Application for Neuroprotection in Glaucoma
2020-05-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
2020-05-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
2020-05-07 07:30U:IMLFFNews ReleaseInMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
2020-05-07 07:30U:IMLFFNews ReleaseInMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
2020-05-05 07:30U:IMLFFNews ReleaseInMed and Almac Group Developing Improved Cannabinoid Production Methods
2020-05-05 07:30U:IMLFFNews ReleaseInMed and Almac Group Developing Improved Cannabinoid Production Methods
2020-04-30 07:30U:IMLFFNews ReleaseInMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
2020-04-30 07:30U:IMLFFNews ReleaseInMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
2020-04-01 07:30U:IMLFFNews ReleaseInMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
2020-04-01 07:30U:IMLFFNews ReleaseInMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
2020-03-24 07:30U:IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
2020-03-24 07:30U:IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
2020-03-20 07:30U:IMLFFNews ReleaseInMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
2020-03-20 07:30U:IMLFFNews ReleaseInMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
2020-03-10 13:24U:IMLFFNews ReleaseInMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
2020-03-10 13:24U:IMLFFNews ReleaseInMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
2020-02-20 09:16U:IMLFFNews ReleaseEdison issues update on InMed Pharmaceuticals (IN)
2020-02-14 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2020-02-14 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2020-02-07 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020
2020-02-07 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Second Quarter Fiscal 2020 Financial Results and Business Update on February 14, 2020
2020-01-21 07:30U:IMLFFNews ReleaseInMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
2020-01-21 07:30U:IMLFFNews ReleaseInMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
2020-01-20 07:30U:IMLFFNews ReleaseInMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
2020-01-20 07:30U:IMLFFNews ReleaseInMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
2020-01-16 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress
2020-01-16 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress
2020-01-10 17:56U:IMLFFNews ReleaseInMed Announces Election of Directors
2020-01-10 17:56U:IMLFFNews ReleaseInMed Announces Election of Directors
2020-01-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Biotech Showcase Conference
2020-01-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Biotech Showcase Conference
2019-12-09 08:35U:IMLFFNews ReleaseGlobal OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
2019-12-09 08:35U:IMLFFNews ReleaseGlobal OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
2019-12-09 07:30U:IMLFFNews ReleaseInMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
2019-12-09 07:30U:IMLFFNews ReleaseInMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
2019-12-02 08:35U:IMLFFNews ReleaseLive Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
2019-12-02 08:35U:IMLFFNews ReleaseLive Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
2019-11-25 08:35U:IMLFFNews ReleaseLive Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th
2019-11-25 08:35U:IMLFFNews ReleaseLive Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th
2019-11-11 08:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Cowen Conference
2019-11-11 08:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Cowen Conference
2019-11-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2019-11-08 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2019-11-05 07:30U:IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
2019-11-05 07:30U:IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
2019-11-04 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
2019-11-04 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
2019-10-18 12:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the BIO Investor Forum
2019-10-18 12:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the BIO Investor Forum
2019-09-23 11:00U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
2019-09-23 11:00U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
2019-09-19 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-09-19 07:30U:IMLFFNews ReleaseInMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-09-12 11:00U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
2019-09-12 11:00U:IMLFFNews ReleaseInMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
2019-09-03 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-09-03 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-29 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
2019-08-29 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
2019-08-02 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
2019-08-02 07:25U:IMLFFNews ReleaseInMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes